Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (DRKS00041145) titled 'Assessment of Global Brain Atrophy and Specific Brain Regions in Patients with Multiple Sclerosis' on July 28.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: Prognosis
Primary Sponsor: Universitatsklinikum Essen
Condition:
Multiple sclerosis (MS), a chronic inflammatory disease of the central nervous system characterized by progressive loss of brain volume (brain atrophy).
Intervention:
Group 1: Retrospective analysis of MS patients (= 18 years, confirmed MS diagnosis according to the 2025 McDonald criteria) treated with cladribine. Using MRI scans perfor...